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a Department of Clinical Sciences and Community Health, Universita degli Studi di Milano, Milan; b Dipartimento per la
Salute della Donna, del Bambino e del Neonato, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan;
c ART Unit, Azienda Socio Sanitaria Territoriale Lariana, Como, ItalyObjectives: To establish the risk factors for monozygotic twin (MZT) and monochorionic twin (MCT) pregnancies after in vitro fertil-
ization (IVF).
Design: Systematic review and meta-analysis.
Setting: Not applicable.
Patient(s): Women who achieved MZT and non-MZT pregnancies through IVF.
Intervention(s): Systematic search of Medline from January 1995 to October 2018 with cross-checking of references from relevant
articles in English.
Main Outcome Measure(s): Possible risk factors for MZT or MCT pregnancies after IVF, comprising extended embryo culture, insem-
ination method (conventional IVF and intracytoplasmic sperm injection [ICSI]), embryo biopsy for preimplantation genetic testing for
aneuploidies or for monogenic/single-gene defects (PGT-A or PGT-M) programs, assisted hatching (AH), oocytes donation, female age,
and embryo cryopreservation.
Result(s): A total of 40 studies were included. Blastocyst transfer compared with cleavage-stage embryo transfer, and female age
<35 years were associated with a statistically significant increase in the MZT and MCT pregnancy rate after IVF: (23 studies, OR
2.16, 95% CI, 1.74–2.68, I2¼78%; 4 studies, OR 1.29; 95% CI, 1.03–1.62, I2¼62%; and 3 studies, OR 1.90, 95% CI, 1.21–2.98,
I2¼59%; 2 studies, OR 2.34; 95% CI, 1.69–3.23, I2¼0, respectively). Conventional IVF compared with ICSI and assisted hatching
were associated with a statistically significantly increased risk of MZT pregnancy (9 studies, OR 1.19, 95% CI, 1.04–1.35, I2¼0; 16
studies, OR 1.17, 95% CI, 1.09–1.27, I2¼29%, respectively). Embryo biopsy for PGT-A or PGT-M, embryo cryopreservation, and
oocytes donation were not associated with MZT pregnancies after IVF.
Conclusion(s): Blastocyst transfer is associated with an increased risk of both MZT and MCT pregnancies after IVF. Further evidence is
needed to clarify the impact of female age, insemination method and AH on the investigated outcomes. (Fertil Steril 2019;111:302–17.
2018 by American Society for Reproductive Medicine.)
El resumen está disponible en Español al final del artículo.
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Medicine, Published by Elsevier Inc.vent concurrent natural conception
and embryo splitting, which are only
seemingly noniatrogenic occurrences.
Indeed, several publications have raised
concern over the increased rate of
monozygotic twin (MZT) pregnancies
after ART when compared with natural
conception (4). In an attempt to reach
an estimation of the incidence of MZT
pregnancies after ART, Vitthala et al.
(5) conducted a meta-analysis that
included 27 studies published between
1993 and 2007. The overall incidence
of MZT pregnancies was 0.9% (95%VOL. 111 NO. 2 / FEBRUARY 2019
Fertility and Sterility®confidence interval [CI], 0.8–0.9%). However, the majority of
studies included were underpowered to estimate such an un-
common event. It is thus not surprising that many investiga-
tors subsequently have tried to provide a more realistic
estimate by analyzing larger cohorts of patients who had un-
dergone in vitro fertilization (IVF), including conventional
IVF, intracytoplasmic sperm injection (ICSI), and fresh and
frozen embryo transfer. It is interesting that almost all the
studies reported higher incidences, ranging from 0.97%
(95% CI, 0.47–1.99%) to 2.35% (95% CI, 2.07–2.67%) (4–20).
These results have raised considerable clinical concern.
Monozygotic twin pregnancies carry a much higher risk of
maternal and fetal complications than singleton and dizygotic
pregnancies, including increased rates of premature delivery,
growth discordance, developmental anomalies, and perinatal
morbidity and mortality (19). Monochorionic placentation is
associated with additional risks due to the specific angioarch-
itecture of monochorionic placentas, which can lead to the
formation of intertwin anastomoses and thus to the develop-
ment of pathologic conditions such as twin-twin transfusion
syndrome, twin anemia-polycythemia sequence, single intra-
uterine fetal demise, and selective intrauterine growth restric-
tion (11, 21, 22).
Many investigators have hypothesized that the afore-
mentioned increased MZT rate is determined by factors asso-
ciated with the IVF techniques themselves. Because MZT and
monochorionic twin (MCT) pregnancies have worrying com-
plications, we conducted a systematic review and meta-
analysis to identify risk factors for their onset after IVF. In
particular, our systematic review with meta-analysis ad-
dressed the question of whether extended embryo culture,
the insemination method (conventional IVF and ICSI), em-
bryo biopsy for preimplantation genetic testing for aneu-
ploidies or for monogenic/single gene defects (PGT-A or
PGT-M) programs, assisted hatching (AH), oocytes donation,
female age, or embryo cryopreservation represented a risk
factor for MZT/MCT pregnancies in couples undergoing IVF.
MATERIALS AND METHODS
Our literature overview was conducted according to the
PRISMA guidelines for systematic reviews (23, 24). Because
published deidentified data were used, this study was
exempt from institutional review board approval. Most of
the published studies did not distinguish between
monochorionic and dichorionic twin pregnancies. For this
reason, we used the generic acronym ‘‘MZT’’ to refer to the
monozygotic pregnancies reported in these studies. When
the investigators specifically referred to monochorionic twin
pregnancies, we used the acronym ‘‘MCT.’’Sources
Our review was restricted to published research articles that
investigated possible risk factors for MZT or MCT pregnancies
after IVF. We searched the Medline database for publications
dating from January 1995 to July 2018. The searches were
limited to studies in humans and were conducted using the
following terms: monozygotic AND in vitro fertilisation OR
IVF OR intracytoplasmic sperm injection OR ICSI OR assistedVOL. 111 NO. 2 / FEBRUARY 2019hatching OR blastocyst OR cleavage stage embryos OR preim-
plantation genetic testing for aneuploidies OR PGT-A OR pre-
implantation genetic testing for monogenic/single gene
defects OR PGT-M OR female age ORmaternal age OR oocytes
donation OR eggs donation OR frozen embryos OR thawed
embryos. We repeated the same search replacing the term
‘‘monozygotic’’ with the term ‘‘monochorionic.’’ The last
search was performed on October 15, 2018.
Published cohort (retrospective or prospective), case con-
trol studies, and randomized clinical trials were eligible for in-
clusion. All pertinent articles were retrieved, and the relative
reference lists were systematically reviewed to identify further
reports that could be included in the meta-analysis. Moreover,
review articles andmeta-analysis published onMZT pregnan-
cies during the same time span were consulted as well, we
searched their reference lists for potential additional studies.
No attempt was made to identify unpublished studies.Study Selection and Quality Assessment
Two authors (A.B. and C.D.) independently performed an initial
screening of all the titles and abstracts to exclude any citations
deemed irrelevant by both observers. In cases of doubt, the
studies were discussed in consensus meetings with two other
authors (L.F. and A.P.). Studies were excluded if [1] the clinical
pregnancy rate was not reported, [2] ART procedures were used
other than IVF (which comprises conventional IVF, ICSI, fresh
and frozen embryo transfer), [3] crude or adjusted effect esti-
mates with corresponding 95% CI or results allowing calcula-
tion of odds ratios (OR) were not reported, or [4] data overlap
between two studies was observed. Case reports, letters to the
editor, and reviews were also excluded.
The diagnosis of chorionicity was considered adequate if
it was determined before 13 þ 6 weeks of gestation by iden-
tification of the ‘‘T’’ sign or the ‘‘lambda’’ sign, measurement
of the intertwin membrane thickness, or determination of the
number of placental masses (25). Studies reporting different
or less accurate diagnostic methods were excluded.
Reports were classified according to the study design into
case control studies, prospective and retrospective cohort
studies, or randomized clinical trials. The quality of case con-
trol and cohort studies was evaluated by means of the
Newcastle-Ottawa scale, a validated tool for assessing the
quality of observational and nonrandomized studies (26).
The scale uses a score system based on three major criteria: se-
lection of participants, comparability of study groups, and
assessment of exposure. The quality checklist includes eight
items with a score of either 0 or 1 for each item except for
‘‘comparability of cohorts,’’ where a score of 0, 1, or 2 can
be awarded. Therefore, the quantitative appraisal of the over-
all quality of each individual study ranged from 0 to 9. No
cutoff score was set for inclusion in the meta-analysis. To
gain insight into the methodological quality and validity of
the trials we used the CONSORT 2010 checklist (27).Data Extraction and Analysis
Three authors (A.B., E.S., and M.R.) independently evaluated
all articles and extrapolated the data on standardized forms.303
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONA final abstraction form was compiled from the three evalu-
ation forms, after resolution of all the discrepancies among
reviewers through a discussion with the two remaining au-
thors. The year of publication, location, study design, study
period, type of placentation, MZT pregnancies diagnosis
method, embryo culture media used, and investigated risk
factors were recorded.
The investigated risk factors were as follows: embryo
extended culture (blastocyst transfer vs. cleavage-stage em-
bryo transfer), AH, insemination method (conventional IVF
and ICSI), embryo biopsy for PGT-A or PGT-M, female age,
oocytes donation, and frozen-thawed embryo transfer. The
risk factors for monochorionic pregnancies were investigated
separately.
From each selected article we extracted the information
on study characteristics, incidence of MZT or MCT pregnan-
cies, and quality of the evidence. Data were used to construct
2  2 tables reporting the investigated risk factor and the
number of MZT or MCT pregnancies and singleton pregnan-
cies. So that we could compare the data from various studies,
we harmonized the definitions and cutoffs of risk factors
among the studies whenever possible.
Irrespective of the method used in the original publica-
tions, our results are expressed as OR with 95% CI (28). Risk es-
timates greater than 1 indicate an increased risk of the defined
outcome; risk estimates less than 1 indicate a decreased risk of
the defined outcome. We assessed statistical significance using
95% CI: if the 95%CI did not include the neutral value 1, we
considered the risk statistically significant.
The inconsistency of the studies' results wasmeasured us-
ing Cochrane Q and the I2 statistic (29). Negative values of I2
are set equal to 0 so that I2 lies between 0 and 100%. Accord-
ing to the Cochrane Handbook for Systematic Reviews of
Intervention, an I2 value of 0 indicates no observed heteroge-
neity, whereas I2 values from 30% to 60% may represent
moderate heterogeneity, I2 values from 50% to 90% may
represent substantial heterogeneity, and I2 values from 75%
to 100% represent considerable heterogeneity (24, 29). If the
I2 values indicated moderate, substantial, or considerable
heterogeneity, we conducted sensitivity analyses to verify
whether any one of the included studies unduly influenced
the pooled effect size.
The OR were combined in a meta-analysis using a fixed-
effects model when the heterogeneity found among the
studies was absent to moderate (0% I2< 30%). When hetero-
geneity was moderate, substantial, or considerable (l2 R
30%), we used the DerSimonian and Laird method (30, 31)
for a random-effects model (28).
Funnel plots, which graph OR on a log scale (effect)
against standard error of log-OR (precision), were generated
and visually inspected for asymmetry to determine whether
the included studies were nonrepresentative of the body of
possible studies on the subject (as could result from a
small-study effect or other biases, such as publication and
poor-quality bias). The approach by Egger et al. (32) was
used to test the significance of funnel plot asymmetry
(32). All analyses were performed using Review Manager 5
(RevMan 5; Cochrane Collaboration) or Stata, version 13
(StataCorp).304RESULTS
Results of Search and Description of Studies
Supplemental Figure 1 (available online) summarizes the pro-
cess of literature identification and selection of studies for the
risk factors assessment. Our literature searches yielded 264
studies, from which 16 duplicates were removed. After a re-
view of the titles and abstracts, 68 studies were identified as
potentially eligible for inclusion. After a full review, we
excluded four systematic reviews or meta-analysis (33–36),
12 case reports (2, 33, 37–46), two letters to the editor
(47, 48) five publications because the data were not
extractable (11, 17, 49–51), three publications because the
monozygotic clinical pregnancy rates were not reported
(3, 52), and one publication because ART techniques other
than conventional IVF and ICSI were used (i.e., subzonal
insemination) (53, 54). The two studies conducted by
Knopman et al. (8, 13) featured considerable overlap, so the
study published in 2010 was excluded (8). Data on the risk
factors for MZT after IVF or ICSI were extracted from the
remaining 40 articles, all of which were published in peer-
reviewed journals between 1998 and 2018 (4, 6, 7, 9, 12–16,
19, 20, 55–82).
Details of the characteristics of the selected studies are
shown in Table 1. One of the included studies was a prospec-
tive cohort study, 30 were retrospective cohort studies, one
was a nested case-control study, and eight were prospective
randomized trials. The potential risk factors that could be
pooled included embryo extended culture (blastocyst transfer
vs. cleavage-stage transfer), assisted hatching, fertilization
technique used (ICSI vs. conventional IVF), oocyte donation,
embryo biopsy for PGT-A or PGT-M, and female age.Extended Embryo Culture
Twenty-three of the included studies investigated whether
prolonged embryo culture may affect the risk of MZT (4, 6,
7, 9, 12–15, 19, 60, 61, 63–67, 71, 72, 76–78, 81, 82).
Pooling of results from the studies showed that blastocyst
transfer was associated with a statistically significant
increase in MZT pregnancy risk when compared with
cleavage-stage embryo transfer. Considering the I2 value
(78%) indicating considerable heterogeneity and the high
clinical heterogeneity between the studies, the pooled OR
was derived using a random-effects model (OR 2.16; 95%
CI, 1.74–2.68; P< .00001) (Fig. 1). A funnel plot showed no
indication of asymmetry among the studies (Supplemental
Fig. 2, available online). The association between blastocyst
transfer and MZT pregnancy risk was also confirmed after
limiting the analysis to high-quality cohort (Newcastle-
Ottawa scale score >7) and case control studies (random-ef-
fects model, OR 1.88; 95%CI, 1.54–2.30; P< .00001; I2¼62%).Assisted Hatching
Sixteen of the included studies investigated a possible associ-
ation between AH andMZT after IVF (4, 12, 13, 18, 19, 55–58,
72, 73, 77–79, 81, 82). The pooling of results from the studies
showed a statistically significant association between AH and
MZT pregnancies after IVF (OR 1.17; 95% CI, 1.09–1.27;VOL. 111 NO. 2 / FEBRUARY 2019
TABLE 1
Included studies investigating potential risk factors for monozygotic twinning after in vitro fertilization.
Study Year Country
Study
design Study period Twinning
Method of
diagnosis
Embryos
culture
media
Fresh and/
or frozen ET
Risk factors
investigated
Quality of
evidencea
Meldrum et al. (55) 1998 USA Retrospective 1990–1996 MZT NR Modified Ham's FI0 NR AH (acidified Tyrode's
solution)
6
Hershlag et al. (56) 1999 USA Retrospective 1990–1996 MZT US and
placental
histology
NR NR AH (Mechanical) 8
Hurst et al. (72) 1998 USA Prospective
randomized
trial
NR MZT NR HTF with HEPES and
15% SSS overlain
with oil
Fresh AH (acidified Tyrode's
solution)
NA
Lanzendorf et al. (73) 1998 USA Prospective
randomized
trial
1995–1996 MZT NR Ham's FI0 NR AH (acidified Tyrode's
solution)
NA
Schieve et al. (57) 2000 USA Retrospective 1996 MZT US NR Fresh AH (specific procedure
not reported)
7
Saito et al. (54) 2000 Japan Retrospective 1994–1995 MZT NR NR NR Microinsemination
procedures
7
Sills et al. (58) 2000 USA Retrospective 1995–1998 MZT US and
placental
examination
at delivery
NR Fresh and
frozen
AH (acidified Tyrode's
solution),
insemination
method, oocytes
donation
8
Schachter et al. (59) 2001 Israel Retrospective 1997–1999 MZT US NR NR Insemination method,
AH (acidified
Tyrode's solution)
6
Da Costa et al. (60) 2001 Brasil Retrospective 1996–1999 MZT US S1 and S2 medium
(Scandinavian IVF
Science)
NR Embryo extended
culture
7
Sheiner et al. (61) 2001 Israel Prospective 1998–1999 MZT NR NR NR Embryo extended
culture
7
Karaki et al. (74) 2002 Jordan Prospective
randomized
trial
1999–2000 MZT NR IVF medium
(MediCult), G1.2
and G2.2 media
(Scandinavian IVF
Sciences)
Fresh Embryo extended
culture
NA
Tarlatzis et al. (62) 2002 Greece Retrospective 1999–2000 MZT US NR NR Insemination method 7
Alikani et al. (63) 2003 USA Retrospective 1995–2002 MZTb US NR Fresh and
frozen
Insemination method,
embryo extended
culture
8
Emiliani et al. () 2003 Belgium Prospective
randomized
trial
NR MZT US In-house sequential
media
Fresh and
frozen
Embryo extended
culture
NA
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TABLE 1
Continued.
Study Year Country
Study
design Study period Twinning
Method of
diagnosis
Embryos
culture
media
Fresh and/
or frozen ET
Risk factors
investigated
Quality of
evidencea
Milki et al. (64) 2003 USA Retrospective 1998–2002 MZT US P1 and blastocyst
medium (Irvine
Scientific)
NR Embryo extended
culture, AH
(acidified Tyrode's
solution),
insemination
method
8
Jain et al. (65) 2004 USA Retrospective 1997–2000 MZT US P-1 media (Irvine
Scientific) and
Blastocyst Media
(Irvine Scientific)
NR Embryo extended
culture
7
Wright et al. (66) 2004 USA Retrospective 1999–2000 MZT US NR Fresh Embryo extended
culture
7
Kolibianakis et al. (76) 2004 Belgium Prospective
randomized
trial
2001–2003 MZT US Sequential media
(Vitrolife,
G€othenburg,
Sweden)
NR Embryo extended
culture
NA
Ng et al. (77) 2005 China Prospective
randomized
trial
2003–2004 MZT NR NR Frozen AH (laser) NA
Ma et al. (78) 2006 Canada Prospective
randomized
trial
1999–2003 MZT US NR NR AH (acidified Tyrode's
solution)
NA
Moayeri et al. (67) 2007 USA Retrospective 2002–2005 MZT US and follow-
up
information
Quinn's Advantage
cleavage-stage
medium
NR Embryo extended
culture
8
Skiadas et al. (68) 2008 USA Retrospective 1998–2004 MZT-MC US P1 (Irvine Scientific) or
IVF-500, G1.2 or
G1.3 (Scandinavian
IVF Science/
Vitrolife); from days
3–5: sequential
media marketed for
use with the
corresponding
medium for days
1–3
NR Embryo extended
culture, AH
(acidified Tyrode's
solution),
insemination
method
8
Balakier et al. (79) 2009 Canada Prospective
randomized
trial
2005–2006 MZT US and records
review
NR NR AH (laser) NA
Verpoest et al. (69) 2009 Belgium Retrospective 2001–2006 MZT US MediCult BlastAssist
system, Vitrolife G2
andG3 series, Cook
Medical Sydney IVF
medium
NR PGT-M 8
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TABLE 1
Continued.
Study Year Country
Study
design Study period Twinning
Method of
diagnosis
Embryos
culture
media
Fresh and/
or frozen ET
Risk factors
investigated
Quality of
evidencea
Sharara and Abdo (7) 2010 USA Retrospective 2003–2008 MZT US P1 (Irvine Scientific),
Global Medium
(Life Global),
Blastocyst Medium
(Irvine Scientific)
Fresh Embryo extended
culture
8
Papanikolaou et al. (6) 2010 Belgium Retrospective 2003–2005 MZT US and follow
up
information
Media A (MediCult)
and Media B
(Vitrolife)
Fresh Embryo extended
culture
8
Kawachiya et al. (9) 2011 Japan Retrospective 2002–2008 MZT US Cleavage-stage
medium (SAGE),
blastocyst medium
(Quinn's
Advantage; SAGE)
Fresh and
frozen
Embryo extended
culture
7
Kang et al. (70) 2012 South Korea Retrospective 2008–2009 MZT US MRC D16 medium (YS
medium)
Fresh Embryo culture (morula
vs. blastocyst
transfer)
7
Nakasuji et al. (12) 2014 Japan Retrospective 2010 MZT US NR Fresh and
frozen
AH (specific procedure
not reported),
embryo extended
culture
7
Knopman et al. (13) 2014 USA Nested case
control
2000–2009 MZTc US, genetic
testing and
placental
pathology
Quinn's cleavage and
blastocyst media
Fresh and
frozen
Oocytes donation, AH
(acidified Tyrode's
solution),
insemination
method, embryo
extended culture,
PGT-A/PGT-M,
female age,
estrogen peak level,
cycle year
8
Wu et al. (71) 2014 Taiwan Retrospective 2001–2011 MZT US Cleavage culture
medium
equilibrated with
6% CO2 in air and
blastocyst culture
medium (Cook IVF)
Fresh Embryo extended
culture,
insemination
method, AH (laser)
8
Franasiak et al. (14) 2015 USA Retrospective 1999–2014 MZT US and records
review
Quinn's Advantage
(CooperSurgical)
followed by
BlastAssist (Origio)
Fresh Embryo extended
culture, female age,
transfer order,
embryology
parameters
8
Busnelli. Monozygotic twinning after IVF. Fertil Steril 2018.
V
O
L.111
N
O
.2
/FEBRU
A
RY
2019
3
0
7
Fertility
and
Sterility®
TABLE 1
Continued.
Study Year Country
Study
design Study period Twinning
Method of
diagnosis
Embryos
culture
media
resh and/
frozen ET
Risk factors
investigated
Quality of
evidencea
Sotiroska et al. (15) 2015 Macedonia Retrospective 2008–2013 MZT US Quinn's Advantage
sequential media
under mineral oil
(SAGE, Cooper
Surgical)
Fr h Embryo extended
culture
8
Tocino et al. (16) 2015 Spain Retrospective 1995–2013 MZTc US NR Fr h and
rozen
Embryo extended
culture
8
Kanter et al. (18) 2015 USA Retrospective 2003–2012 MZT US and delivery
data
NR Fr h Female age, ethnicity,
infertility diagnosis,
obstetric and ART
history, embryo
extended culture,
insemination
method, AH
(specific procedure
not reported),
supernumerary
embryos, number
of oocytes retrieved
8
Vaughan et al. (19) 2016 USA Retrospective 2002–2013 MZT US and records
review
NR Fr h Ovarian stimulation,
insemination
method, embryo
extended culture,
cycle year, female
age, oocytes
donation, embryo
biopsy, AH (specific
procedure not
reported), number
of embryos
transferred
8
Mateizel et al. (4) 2016 Belgium Retrospective 2004–2013 MZTc US Irvine HTF medium,
Cook IVF media,
Vitrolife sequential
media, MediCult,
EmbryoAssist,
BlastAssist
Medium, Sage
Quinn's Advantage
Protein Plus
cleavage and
blastocyst media
Fr h and
rozen
Female age, embryo
extended culture,
oocyte donation,
insemination
method, PGT-M,
AH (specific
procedure not
reported)
8
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TABLE 1
Continued.
Study Year Country
Study
design Study period Twinning
Method of
diagnosis
Embryos
culture
media
Fresh and/
or frozen ET
Risk factors
investigated
Quality of
evidencea
Song et al. (20) 2017 China Retrospective 2011–2016 MZT-MC-DA US NR Fresh and
frozen
Female age, embryo
extended culture,
insemination
method, transfer
order
8
Liu et al. (82) 2018 China Retrospective 2014–2015 MZT US G1 and G2 Plus
medium (Vitrolife)
Fresh and
frozen
Embryo extended
culture,
insemination
method, AH (laser),
stimulation
protocol, number
of transferred
embryos
8
Ikemoto et al. (81) 2018 Japan Retrospective 2007–2014 MZT US NR Fresh and
frozen
Embryo extended
culture,
insemination
method, AH
(specific procedure
not reported)
8
Note: AH¼ assisted hatching; ART¼ assisted reproductive technology; DA¼ diamniotic; HTF¼ human tubal fluid; IVF¼ in vitro fertilization; MC¼monochorionic; MZT¼monozygotic; NA¼ not applicable; NR¼ not reported; PGT-A¼ preimplantation genetic testing
for aneuploidies; PGT_M ¼ preimplantation testing for monogenic/single gene defects; US ¼ ultrasound.
a Based on the Newcastle–Ottawa scale. Wells et al. 2000 (26).
b Chorionicity specified.
c Chorionicity and amnionicity specified.
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FIGURE 1
Embryo extended culture and risk of monozygotic twinning.
Busnelli. Monozygotic twinning after IVF. Fertil Steril 2018.
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONP< .0001) (Supplemental Fig. 3, available online). The I2 value
was 29%. A funnel plot showed no indication of asymmetry
among the studies (Supplemental Fig. 4, available online).
The association was not confirmed after limiting the
analysis to high-quality cohort (Newcastle-Ottawa scale score
>7) and case control studies (random-effects model, OR 1.00;
95% CI, 0.81–1.24, P¼ .99, I2¼53%).Insemination Method
Ten studies investigated the possible impact of the insemina-
tion method (conventional IVF or ICSI) on the rate of MZT
pregnancies (4, 13, 18, 19, 38, 58, 59, 62, 65, 81). Our meta-
analysis showed a statistically significant increase of this
risk after the use of classic IVF (OR 1.13; 95% CI, 1.02–1.26;
P¼ .02) (Supplemental Fig. 5, available online). The I2 value
was 0. Alikani et al. (63) analyzed this risk factor by reporting
the number of IVF-ICSI cycles as a denominator, so this study
could not be included in the meta-analysis. The association
was also confirmed after limiting the analysis to high-quality
cohort (Newcastle-Ottawa scale score >7) and case control
studies (fixed-effects model, OR 1.14; 95% CI, 1.02-1.26;
P¼ .02; I2¼0). Alikani et al. (63) analyzed this risk factor by
reporting the number of IVF-ICSI cycles as a denominator,
so this study could not be included in the meta-analysis. Re-
sults showed the lack of an association (OR 1.50; 95% CI,
0.95-2.37; P¼ .08).Embryo Biopsy for PGT-A or PGT-M
Four studies evaluated the effect of embryo biopsy for PGT-A
or PGT-M on the MZT risk (4, 13, 19, 69). The meta-analysis310showed the lack of an association between these genetic tests
and MZT pregnancies. Considering the I2 value (79%) indi-
cating considerable heterogeneity, the high clinical heteroge-
neity between studies, and the low number of included
studies, the pooled OR was derived using a random-effects
model (OR 1.52; 95% CI, 0.76–3.02; P¼ .23) (Supplemental
Fig. 6, available online). A funnel plot showed no indication
of asymmetry among the studies (Supplemental Fig. 7, avail-
able online). All the included studies were high quality. Two
studies investigated exclusively the effect of PGT-M (4, 69).
Pooling of results showed no association between PGT-M
and monozygotic twinning after IVF (random-effects model,
OR 1.04; 95% CI, 0.56–1.93; P¼ .90; I2 ¼ 51%). Knopman
et al. (13) also investigated the additive effect of ICSI and em-
bryo biopsy (PGT-M/PGT-A) and failed to demonstrate any
association (OR 0.92; 95% CI, 0.22–3.77; P¼1.00).Frozen-thawed Embryos
Eight studies evaluated the impact of frozen-thawed embryo
transfer on the risk of MZT (4, 9, 12, 13, 58, 63, 81, 82). The
meta-analysis did not show any association between frozen
cycles and MZT pregnancies. Considering the I2 value (74%)
indicating considerable heterogeneity and the high clinical
heterogeneity between the studies, the pooled OR was derived
using a random-effects model (OR 1.18; 95% CI, 0.91–1.52;
P¼ .21) (Supplemental Fig. 8, available online). A funnel
plot showed no indication of asymmetry among the studies
(Supplemental Fig. 9, available online). The lack of an associ-
ation was also confirmed after limiting the analysis to high-
quality cohort (Newcastle-Ottawa scale score >7) and caseVOL. 111 NO. 2 / FEBRUARY 2019
Fertility and Sterility®control studies (random-effects model, OR 1.10; 95% CI,
0.72–1.69; P¼ .66; I2¼79%).Female Age
Four studies evaluated the effect of oocyte age on the MZT
risk by estimating the incidence of this event among women
aged 35 or older and younger women (4, 13, 14, 18). The
pooling of the results from studies showed a statistically
significantly increased risk among women younger than
35 years (Fig. 2). Considering the I2 value (62%) indicating
substantial heterogeneity, the clinical heterogeneity
between studies, and the low number of included studies,
the pooled OR was derived using a random-effects model
(OR 1.29; 95% CI, 1.03–1.62; P¼ .03). All the included studies
were high quality. A funnel plot showed no indication of
asymmetry among the studies (Supplemental Fig. 10, avail-
able online).Oocyte Donation
Five studies evaluated the effect of the use of donor oocytes
on the risk of MZT (4, 13, 19, 58, 63). The meta-analysis
showed no association (OR 1.10; 95% CI, 0.82–1.50;
P¼ .52) (Supplemental Fig. 11, available online). The I2 value
was 8%.Miscellaneous
Knopman et al. (13) hypothesized a possible effect of the es-
trogen peak level on the risk of MZT but failed to document
an association (OR 1.08; 95% CI, 0.76–1.55; P¼ .64). Two
studies analyzed the period of time in which the IVF cycle
was performed and its association with the risk of MZT. Knop-
man et al. (13) reported a statistically significantly lower risk
in cycles performed after 2004 (OR 0.68; 95% CI, 0.47–0.96;
P¼ .02). By contrast, Vaughan et al. (19) observed a statisti-
cally significantly higher risk in cycles performed after 2005
(OR 1.56; 95% CI, 0.84–2.91; P¼ .16). Franasiak et al. (14) re-
ported a statistically significantly higher risk of MZT among
patients with supernumerary embryos available (risk ratio
1.59; 95% CI, 1.23–2.06; P¼ .0004).FIGURE 2
Female age and risk of monozygotic twinning.
Busnelli. Monozygotic twinning after IVF. Fertil Steril 2018.
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Three studies specifically provided data on the risk factors for
monozygotic monochorionic twinning (MCT) after IVF
(13, 20, 68). Again, the meta-analysis showed a statistically
significantly increased risk for this event after extended em-
bryo culture (Fig. 3). Considering the I2 value (59%) indicating
substantial heterogeneity, the clinical heterogeneity between
studies, and the low number of included studies, the pooled
effect estimate was derived using a random-effects model
(OR 1.90; 95% CI, 1.21–2.98; P¼ .005). All the included
studies were high quality. The meta-analysis also showed
an association between young female age and risk of MCT
pregnancies after IVF (fixed-effects model, OR 2.34; 95% CI,
1.69–3.23; P< .00001; I2 ¼ 0) (see Fig. 3). The pooling of re-
sults from the studies did not show an association between
ICSI, assisted hatching, and frozen-thawed embryo transfer
and MCT after IVF (see Fig. 3).DISCUSSION
The data from our systematic review and meta-analysis
indicated that blastocyst transfer and younger female age
(i.e., age <35 years) are associated with an increased risk
of both MZT and MCT pregnancies after IVF. The meta-
analysis also showed a milder but still statistically signifi-
cant association between conventional IVF and AH and
the risk of MZT pregnancies. Of note, we failed to document
any association between all the other risk factors extrapo-
lated from the literature (i.e., frozen-thawed embryo trans-
fer, PGT-M or PGT-A, or oocyte donation) and the
occurrence of MZT pregnancies after IVF. Importantly, after
limiting the analysis to high-quality cohort (Newcastle-
Ottawa scale score >7) and case control studies, all our re-
sults were confirmed with the exception of the increased risk
of MZT pregnancies after AH.
Our results are in line with those reported in a recent
meta-analysis by Hviid et al. (36) which showed a statistically
significantly higher rate of MZT pregnancies after blastocyst
transfer than after cleavage-stage embryo transfer (fixed-ef-
fects meta-analysis: OR 2.18; 95% CI, 1.93–2.48 and random-
effects meta-analysis: OR 2.00; 95% CI, 1.48–2.70). The basis
of the association between blastocyst transfer and MZT and311
FIGURE 3
Risk factors for monozygotic monochorionic twinning after IVF. (A) Embryo extended culture and risk of monozygotic monochorionic twinning. (B)
Inseminationmethod and risk of monozygoticmonochorionic twinning. (C) Assisted hatching and risk ofmonozygoticmonochorionic twinning. (D)
Frozen-thawed embryo transfer and risk of monozygotic monochorionic twinning. (E) Female age and risk of monozygotic monochorionic
twinning.
Busnelli. Monozygotic twinning after IVF. Fertil Steril 2018.
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONMCT pregnancies after IVF is not fully understood, but several
not-mutually-exclusive theories have been proposed. For
instance, it has been hypothesized that extended exposure
to culture media may determine the hardening of the zona
pellucida, an acellular area of mucopolysaccharides and spe-312cific proteins surrounding the ovum (11). On this basis, it has
been speculated that spontaneous or assisted hatching of the
blastocyst through a less flexible zona pellucida might in-
crease the risk of splitting of the inner cell mass (ICM) and
the consequent development of two fetal plates (5, 80, 81).VOL. 111 NO. 2 / FEBRUARY 2019
Fertility and Sterility®The components of the culture media and their concen-
trations might also play a role. The long exposure of the em-
bryo to low levels of calcium might destabilize the
intracellular bonds and consequently predispose the ICM to
the division (6, 15, 81). At the same time, the medium used
to grow blastocysts may lead to an overstimulation of
apoptosis through free radical formation due to the
excessive glucose levels. Linear polarization of apoptotic
cells in the ICM could lead to splitting during or before the
hatching process (83). Similarly, growth factors such as
insulin-like growth factors 1 and 2 might induce changes in
signaling pathway, cytoplasmic shifting, or polarity changes
in the embryo, which may increase the MZT risk (15). Accord-
ing to other investigators, it is possible that culture media
devoid of growth factors or cytokines may cause a metabolic
stress to embryos, which is exacerbated by extended culture.
This may translate into higher rates of MZT pregnancies
partly due to increased apoptosis and weaker cell-to-cell
adhesion (64).
The characteristics of the blastocyst itself might also be
involved. It has been hypothesized that the cause of increased
twinning in this situation could be related to blastocyst-stage
embryos being more sensitive to the effects of mechanical
manipulation in the laboratory or transient changes in tem-
perature or pH during monitoring or embryo transfer (11).
It is interesting that data from our meta-analysis also
demonstrate that embryos derived from younger oocytes
(i.e., female age at time of retrieval<35 years) are statistically
significantly more likely to result in a MZT or MCT preg-
nancy. According to Knopman et al. (13), MZT production
is another means by which younger, presumably healthier oo-
cytes demonstrate their superior reproductive potential. This
theory, even if fascinating, is still too vague, and further
data are warranted to deepen the reasons behind this associ-
ation. Furthermore, it must be considered that blastocyst
transfer may act as a confounding factor. In fact, it is well
known that embryos derived from young oocytes are more
likely to be transferred at an advanced blastocyst stage. Un-
fortunately, only Knopman et al. (13) controlled for the asso-
ciation with extended culture, and they reported that the
twinning increase in younger women remained statistically
significant. The available data are thus insufficient to control
the entire meta-analysis investigating the impact of female
age on the risk of MZT for the stage of the transferred embryo.
As a consequence, age might not be an independent risk fac-
tor for MZT but rather a proxy for blastocyst transfer.
The protective effect of ICSI on the risk of MZT pregnan-
cies was unexpected. In fact, the majority of studies on this
topic have speculated that this insemination method could
be encouraging an increase in the frequency of MZT due to
the splitting of the ICM after its herniation through a compro-
mised zona pellucida (52). Hypothesizing a biological mecha-
nism that could justify the association between conventional
IVF and MZT pregnancy risk is thus very difficult. A possible
explanation could be sought in the expansion of ICSI indica-
tions to non-male-factor infertility causes and the conse-
quent preferential use of classic IVF in patients with
good-quality oocytes with a high fertilization potential (84).
In contrast with these results, Hviid et al. (36), on the basisVOL. 111 NO. 2 / FEBRUARY 2019of more than 10 high-quality studies, concluded that there
is no clear consensus regarding the influence of the methods
of fertility treatment on the frequency of MZT. Even if they
had not performed a meta-analysis, this discrepancy was
probably due to the fact that they chose not to include the
study by Kanter et al. (18), which accounts for the highest
weight (61%) in our quantitative analysis and shows an asso-
ciation between conventional IVF and MZT pregnancy risk
(OR 1.21, 95% CI, 1.03–1.43). Considering the weak though
still statistically significant association and the lack of a
rational justification, more studies designed to investigate
this specific aspect and its biological basis are warranted.
According to the most accepted theory, AH might lead to
embryo splitting in two ways: first, a premature disruption in
the zona pellucida can interfere with signaling mechanisms
within the embryo; second, an artificial hole can allow for
blastomere separation and division. Both processes, either
individually or collectively, might thus enhance the risk for
MZT (13). A first analysis seemed to confirm this hypothesis.
However, the pooling of results extrapolated exclusively from
high-quality studies failed to confirm the association. The
available evidence is thus insufficient to draw reliable conclu-
sions regarding the impact of this technique on the investi-
gated outcomes.
The results from our meta-analysis clearly highlight rea-
sons for clinical concern and may have important implica-
tions in the IVF shared decision-making process. Embryo
transfer at the blastocyst stage leads to higher live-birth rates
per embryo transfer episode (85). As a consequence, patients
tend to perceive this strategy as the best for achieving their
goal. However, they often ignore the possible associated
midterm and long-term drawbacks (33, 83–88). In this
regard, our results provide a precise estimate of the
increased risk not only of MZT pregnancies but also of MCT
pregnancies after blastocyst transfer. Considering the
significant potential complications associated with these
events, this information should be communicated to
patients. On the other hand, a critical vision of the whole
picture should not be lost. First, the extent of the
association is not so great as to hypothesize a certain
cause–effect relationship between embryo transfer at blasto-
cyst stage and MZT or MCT pregnancies (89). Second, there
are other aspects that need to be considered during the risk–
benefit assessment when we must choose whether to transfer
an embryo at the cleavage or blastocyst stage. In particular,
the numerous advantages of blastocyst transfer should not
be forgotten, such as the large reduction in the rate of multiple
pregnancies after the worldwide introduction of elective
single-embryo transfer after extended embryo culture (90).
It is thus necessary to perform studies specifically focused
on evaluating the risks, benefits, and costs associated with
each procedure and to develop a decisional algorithm to
help choose the best option.Strengths and Limitations
The present systematic review and meta-analysis included
many studies with heterogeneous populations and provides
the largest sample of women in whom the risk factors for313
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONMZT pregnancies after IVF have been examined. Further-
more, it constitutes the first systematic attempt to establish
risk factors for monochorionic placentation after IVF.
Nevertheless, some limitations of our meta-analysis
deserve to be mentioned. First, in the majority of the included
studies the investigators used ultrasound criteria to diagnose
MZT pregnancies. However, it is well known that the only
reliable way to diagnose zygosity is to perform a DNA
profiling of all multiple same-sex deliveries (16). Second,
the heterogeneity of the included studies partially limits the
findings of our meta-analysis. Third, the association between
conventional IVF and MZT pregnancies is doubtful. This is
more likely a spurious finding attributable to the heterogene-
ity and/or to the quality of available studies. There are several
unconvincing aspects. From a statistical perspective, the OR
magnitude is low and the CI nearly crosses 1. Furthermore,
there are no rational biological bases to support this associa-
tion. Finally, the last study that investigated this aspect was
conducted 18 years after the first one. That the included
studies cover such a long period of time also limits the reli-
ability of the other associations investigated in our meta-
analysis. In this field of medicine innovation is very fast,
and many practices have drastically changed. On the other
hand, although they were not able to fully control this limit,
the subanalyzes we performed on the basis of the study period
did not alter our results.
CONCLUSION
The available data on the relationship between characteristics
of ART and MZT, explored here via meta-analysis, primarily
indicated a robust association between extended culture
and MZT, while finding a lack of association between embryo
biopsy, embryo cryopreservation, and oocytes donation. Our
analysis suggests the possibility of increased MZT among
younger patients, but we found a weak association, with the
lower bound of the 95% CI as 1.03 for OR. In addition, the
available data do not enable us to control appropriately for
extended culture in our analysis, which may be an important
confounder; in fact, the increase in MZT with younger age
may be entirely attributable to the overrepresentation of blas-
tocyst transfer among younger patients. So we caution that
these data do not definitively show younger age to be associ-
ated with MZT. The relative increase in the odds of MZT with
blastocyst transfer was large (116% increase) and highly sta-
tistically significant (P< .00001), but the absolute increase in
MZT attributable to blastocyst culture would be expected to
be quite small (<2%), given the overall low reported incidence
of MZT after ART. Therefore, this analysis should in no way
discourage extended culture performed with the goal of elec-
tive single-embryo transfer, a practice that greatly decreases
twinning from ART.
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Fertility and Sterility®Factores de riesgo relacionados con el origen de gemelos monocigoticos tras fecundacion in vitro: revision sistematica y meta-analisis
Objectivos: Estudiar los factores de riesgo relacionados con el origen de gemelos monocigoticos (GMZ) y monocorionicos (GMC) tras
fecundacion in vitro (FIV).
Dise~no: Revision sistematica y meta-analisis.
Escenario: No aplica.
Pacientes: Mujeres que gestaron GMZ y no GMC tras FIV.
Intervenciones: Busqueda sistematica en Medline de artículos en ingles publicados entre enero de 1995 y octubre de 2018.
Medida de los resultados principales: Posibles factores de riesgo relacionados con el embarazo de GMZ y GMC tras FIV, tales como el
cultivo prolongado, el metodo de inseminacion (FIV convencional y microinyeccion intracitoplasmatica [ICSI]), la biopsia embrionaria
para el diagnostico genetico preimplantacional para la seleccion de aneuploidías o para las enfermedades monogenicas/ de un solo gen
(DGP-A, DGP-M), la eclosion asistida (EA), la donacion de ovocitos, la edad materna y la criopreservacion embrionaria.
Resultados: Un total de 40 estudios fueron incluidos. Se observo un incremento estadísticamente significativo de embarazos de GMZ y
GMC tras FIV cuando se comparo la transferencia en estadio de blastocisto vs. la transferencia en estadio de celulas, así como cuando la
edad materna era <35 a~nos (23 estudios, OR 2.16, 95% IC, 1.74–2.68, I2¼78%; 4 estudios, OR 1.29; 95% IC, 1.03–1.62, I2¼62%; y 3
estudios, OR 1.90, 95% IC, 1.21–2.98, I2¼59%; 2 estudios, OR 2.34; 95% IC, 1.69–3.23, I2¼0, respectivamente). La biopsia embrionaria
para DGP-A o DPG-M, la criopreservacion embrionaria y la donacion de ovocitos no se asociaron con los embarazos de GMZ yGMC tras
FIV.
Conclusiones: La transferencia en estadio blastocisto esta asociada con un incremento de riesgo de embarazos de GMZ yGMC tras FIV.
Para esclarecer el impacto de la edad materna, el metodo de inseminacion y la EC en los resultados investigados, son necesarios mas
evidencias.VOL. 111 NO. 2 / FEBRUARY 2019 317
